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Incidence of Cardiovascular Diseases 
Atherosclerotic cardiovascular diseases are the leading cause of death in 
the United States (1 ,2,3,4) accounting for over half of all deaths annually (3,5). 
This is two to three times greater than the second leading cause of death, cancer 
(1 ,3,5). One fourth of all cardiovascular deaths happen to persons under 65 (3). 
Coronary heart disease (CHD) is insidious, probably beginning in childhood but 
asymptomatic until mid life (1 ). The first symptom is often a fatal heart attack or 
stroke. Half of all CHD deaths occur unexpectedly; seventy percent occur 
outside the hospital (3). 
Cardiovascular Risk Factors 
The prevalence of atherosclerotic disease has lead to intensive research 
into its multifaceted etiology. Exact mechanisms have not yet been elucidated 
but risk factors have been identified. Primary risk factors include genetic 
predisposition, blood lipid levels, hypertension and smoking (1 ,2,3,5). 
Identification of preventative measures are needed. 
A large body of epidemiological, clinical and experimental evidence point 
to a positive correlation between total serum cholesterol, low density 
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lipoproteins (LDL) and atherosclerosis. It is uncertain whether the relationship 
between high blood cholesterol and CHD is causal or associative. However, 
growing consensus is that total serum cholesterol level is a reliable indicator of 
latent risk of CHD and that the magnitude of the problem is too great to await 
definitive proof (1-7). 
A strong negative correlation exists between plasma high density 
lipoprotein (HDL), CHD mortality (3) and lesion growth (8). The total 
cholesteroi:HDL cholesterol ratio is considered the best predictor of CHD risk 
within a population, especially for people over age 55 (3). 
Optimal Total Cholesterol Levels 
Optimal levels of total serum cholesterol have been established which 
correspond to decreased risks of CHD mortality in humans (1 ,2,3,5,7). Blood 
cholesterol levels above 200 - 230 mg/dl are ~onsidered at increased risk of 
premature CHD (1 ,2,5). Fifty percent of the United States population falls in this 
risk category. The risk level has been further divided into moderate and high 
risk. The National Institutes of Health recommend dietary intervention to lower 
blood cholesterol levels, reserving pharmacological treatment for those at 
highest risk (1 ). 
Diet and Atherosclerosis 
The thirty-one percent decline in cardiovascular (CV) disease mortality 
from 1970 to 1980 has coincided with lifestyle and dietary changes and lowering 
of serum cholesterol values (3,8). In 1976 almost half of all Americans had 
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altered their eating patterns for health concerns (8). 
Dietary factors play a significant role in levels of blood lipids. Extensive 
research into effects of specific dietary factors on serum lipids seek to determine 
individual effects, as well as interactions of dietary components, on the 
absorption, transport and metabolism of lipids (5). 
Dietary cholesterol, fat and animal proteins correlate positively with CHD 
mortality (9). Animal proteins have been demonstrated to be more 
cholesterolemic than vegetable proteins. Saturated fats elevate blood 
cholesterol more than unsaturated fats (1 0, 11 ). The role of many minerals has 
yet to be determined. 
Current dietary recommendations deemphasize dairy products (1,3,5). 
Concern exists that such changes to modify cholesterol consumption may be 
harmful (12) and perhaps decrease intake of essential nutrients such as 
calcium, although such a trend has not been confirmed (13). 
Is Calcium Hypocholesterolemic? 
Epidemiologic studies have negatively correlated CV death rates with 
water hardness (14), particularly with water calcium levels (15, 16, 17, 18). 
Animal and human diet studies indicate calcium may be hypocholesterolemic 
(19,20,21) and antihypertensive (22,23,24). 
Intent of Study 
The intent of this study is twofold. First, the effect of two levels of dietary 
calcium on plasma cholesterol and HDL will be examined. Second, the 
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cholesterolemic effect of two protein sources, animal (casein) and vegetable 
(soy) will be compared. Japanese quail (Coturnix coturnix japonica) will be 




Physiological Role of Calcium 
Calcium is the most abundant essential mineral in the body. Ninety-nine 
percent is in the skeleton and teeth. The remaining one percent, in the body 
fluids and cells, is involved in regulation of important functions including normal 
muscle and nerve function, maintenance of the intracellular environment and 
hormonal action (25,26). Calcium is a "second messenger" mediating cellular 
responses to a variety of stimuli. Plasma calcium levels are narrowly maintained 
in man at 9-11 mg/dl ± 3%. Vitamin D, parathyroid hormone, calcitonin and 
other hormones regulate plasma calcium levels (27,28). 
Despite the crucial role of calcium, controversy exists on the required daily 
intake of dietary calcium (27,28). Total body calcium is regulated primarily by 
the amount of dietary calcium absorbed (28). The United States Recommended 
Dietary Allowance (RDA) is 800 mg daily, twice the FAO/WHO Committee on 
Calcium Requirements recommended 400-500 mg daily. The RDA is 
considered too low, especially for the elderly, by many (28) to maintain calcium 
balance and in excess by others (27). 
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Different diets and physiological states effect calcium bioavailability. The 
efficiency of calcium absorption increases when intakes of calcium are low (27, 
28,29). It has been assumed that the rate of calcium absorption will "adapt" to 
low calcium intakes so that dietary intake is not crucial. Recent observations 
suggest, however, that such adaption is not sufficient to maintain calcium 
balance and optimal bone mineralization (28). 
Intestinal Absorption and Transport of Calcium 
Evidence suggests that calcium levels are well regulated at the level of 
absorption (26). Only a portion of dietary calcium is absorbed. The fraction that 
is absorbed depends on the presence of other dietary components, the calcium 
and vitamin D, and the physiological state of the individual (i.e., growth or 
pregnancy) (28). Urinary excretion of calcium, in man, occurs when blood 
calcium exceeds 7 mg/dl and since plasma calcium is regulated betweehn 9 -
11 mg/dl urinary calcium excretion remains relatively constant. Fecal excretion 
of calcium varies in response to diet (26) and this variation is assumed to reflect 
changes in calcium absorption (28). 
Dietary calcium is usually complexed with other dietary constituents. The 
calcium must be released in a soluble, and probably ionized form to be 
absorbed (28). Fecal calcium tends to increase in high protein diets (26). The 
formation of insoluble calcium soaps (with fatty acids) or inorganic calcium salts 
(with oxalates, phytates and phosphates) inhibit calcium absorption (26). 
Gastric acid seems to increase solubility of calcium complexes (28). 
Calcium precipitates from solution with a pH over 6.1. Calcium binding proteins 
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(CaBP) in the intestinal mucosa bind and play a role in absorption of calcium. 
Synthesis of these proteins are induced by vitamin D in low calcium diets 
(26,29). Calcium binding proteins are found mainly in the duodenum and upper 
jejunum where calcium absorption primarily occurs (28). 
Solubility of calcium salts in vitro and intestinal absorption of calcium is 
increased by bile. Bile salts are needed for optimal vitamin D absorption. In 
man, calcium salts present in bile acids seldom precipitate and bile calcium may 
be preferentially absorbed. Bile is a route of secretion of calcium into the 
intestine (28). 
Calcium absorption is not completely understood but appears to happen 
by two mechanisms: a nonsaturatable, simple passive diffusion and a 
saturatable transepithelial carrier mediated process. The latter is most 
significant when the interluminal calcium concentration is low. Diffusion is most 
important when large calcium concentration gradients exist (29). The carrier 
mediated transport probably accounts for increased calcium absorption with low 
dietary intakes or when physiological demand for calcium is high (25,29). 
Dietary Calcium and Cardiovascular Disease 
The "Water Story". Epidemiological evidence suggests some minerals in 
water may effect the development of cardiovascular disease, especially 
hypertension and atherosclerosis. Studies have found cardiovascular death 
rates inversely correlated with drinking water hardness (15, 16, 17,30). 
Schroeder (31) found the range of cardiovascular deaths to be nearly forty-three 
percent less annually in New Mexico, a hard water state, than South Carolina, a 
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soft water state. The protective or enhancing substance in water has not been 
identified (30) but may be due to one of the principle cations (calcium or 
magnesium) that contributes to water hardness (17). 
A study in England and Wales found cardiovascular mortality altered in 
boroughs where the water hardness had changed substantially over a thirty year 
period. Cardiovascular death rates decreased in towns where the water had 
become harder and increased where it had become softer; noncardiovascular 
mortality did not correlate with water hardness changes (31 ). Another 
English-Welsh study found highly negative correlations between water hardness 
and CV mortality which were even more negatively correlated with water 
calcium (31 ). 
In areas where the water is "hard", drinking water accounts for seven 
percent (17) to fifteen percent (32) of man's total mineral intake of calcium and 
twelve percent (17) for magnesium. The magnesium value is probably 
overestimated due to lack of nutrient data for magnesium in food (17). 
A postulated mechanism for the protective effect of calcium or magnesium 
is that these minerals may protect against the uptake of potentially toxic metals 
(Mn and Pb) from the gut. Calcium and lead may compete for CaBP. It is not 
known whether increased uptake of Mn and Pb is a risk factor for CV disease 
(16). 
The Hypocholesterolemic Factor(s) In Milk 
Dairy products are high in saturated fats and cholesterol, which are 
hypercholesterolemic. Evidence suggests, however, that milk products may 
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contain a hypocholesterolemic factor. Possible hypocholesterolemic factors 
include: hydroxymethyl glutarate, orotic acid, lactose and calcium (33,34). 
Mann (35) found low CVD and serum cholesterol in the Masaii who have 
a high intake of milk and meat. Thakur and Jha (33) found yoghurt, milk and 
calcium supplemented diets to reduce dietary cholesterol induced 
hypercholesterolemia in rabbits. Yoghurt and calcium diets were more 
hypocholesterolemic than milk diets. Milk and yoghurt consumed in this study 
had equivalent calcium. This suggests calcium is hypocholesteroemic but that 
other factors may be present. 
Hepner (36) reports the hypocholesterolemic effect of yoghurt may be due 
to its significant calcium content, supplying 864 mg/day in his study. The 
hypocholesterolemic factor in yoghurt is not due to the pasteurization or non-
pasteurization of yoghurt (36). 
Studies of male prisoners found no significant change in serum 
cholesterol, triglycerides of high density lipoproteins in control, skim milk, or 
buttermilk diets (34). Rat diet studies have found milk not to be hypolipidemic or 
hyperlipidemic. Compared to the control diet, however, the milk diet did not 
raise lipid levels despite ingestion of fifty percent more fat, nine milligrams of 
cholesterol a day and thirty-five percent less fiber (37). 
Rossouw et al. (38) varied human diets with skim milk, yoghurt and full 
cream. Serum cholesterol was lower with skim milk and increased at two weeks 
with yoghurt and full cream. The changes correlate with dietary fat and 
cholesterol intakes. No convincing evidence of a hypocholesterolemic milk 
factor was seen. The high density lipoprotein (HDL) particles are considered 
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protective against atherosclerosis; they increased with each of the three diet 
treatments. 
A metabolic ward study featuring a high calcium control (2600 mg/day), a 
low calcium control (800 mg/day) and a high calcium skim milk diet (2600 
mg/day) indicated no hypocholesterolemic factor in milk (39). On the high 
calcium control the plasma cholesteroi:HDL ratio decreased and the 
triglycerides in LDL increased. On high calcium skim milk the plasma 
cholesteroi:HDL ratio decreased. HDL decreased, plasma cholesterol and LDL 
increased. The plasma cholesterol in the skim milk diet was about ten percent 
higher in seventy-eight percent of the subjects than in the high calcium control, 
but this difference was not statistically significant. 
Cottage cheese is not hypocholesterolemic suggesting the 
hypocholesterolemic factor is in whey. Whey consists of whey protein, lactose, 
vitamins and mineral salts, including calcium. Howard and Marks (40) found 
only butter to be hypercholesterolemic. There was a lack of effect of lactose and 
lactose plus calcium and magnesium suggesting that the cholesterol lowering 
factor is not lactose or lactose in combination with mineral salts (40). 
Lactose increases cholesterol absorption while calcium has been known 
to decrease cholesterol absorption in lactose containing diets. Wells and 
Cooper (41) saw two percent calcium chloride in a lactose diet lowered total 
liver cholesterol and ended mild diarrhea in lactose fed rats. When added to 
fat-free diets calcium chloride had no effect on cholesterol absorption or 
lowering of liver cholesterol levels. 
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The hypocholesterolemic factor in milk and yoghurt may be calcium or it 
may be calcium in association with other, as yet unknown factors. 
Dietary Calcium and Serum Lipid Levels 
Animal and human experiments indicate that dietary calcium is 
hypolipidemic. Yacowitz, et al. (42) fed Holtzman rats corn oil or saturated fat at 
three calcium levels (.08, .2, and 1.2%) and found dietary calcium to be 
hypocholesterolemic and hypotriglyceridemic for both fats, but with greater effect 
in saturated fat diets (42). At the 1.2% calcium level in cocoa butter diets, serum 
total lipids were reduced to levels comparable to those on the corn oil diet. 
Addition of 1 .2% calcium lowered cholesterol and triglycerides with both fats. 
Fleishman et al. (43) fed Holtzman rats a corn-soy ration with 15.63% 
protein, beef tallow and 2% added cholesterol. Calcium was added as calcium 
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carbonate at 0.08, 0.2 and 1.2% levels. Blood lipids decreased with increasing 
calcium. The major decline occurred at 0.2% calcium with a small, additional 
decrease in total cholesterol and serum lipids at 1.2%. In another study 
Fleischman, et al. (44) fed Holtzman rats diets with 2% calcium carbonate, 
calcium carbonate plus o2 and oyster shell calcium plus o2. Serum cholesterol 
levels were lower than control by 35%, 27%, and 22% respectively. 
Triglycerides were lowered by 10%, 10% and 17%. The hypotriglyceridemic 
effect of oyster shell calcium may be due to the increased magnesium and zinc 
content of oyster shell calcium; both are known to be hypolipemic. Serum 
phospholipids decreased in calcium carbonate supplemented diets, but 
remained the same in the oyster shell group. Serum free fatty acids (FFA) were 
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32% higher in the calcium carbonate diets and 55% higher in the oyster shell 
group. 
Goats fed a calcium supplement had a 16.6% decrease in plasma 
cholesterol from the basal milk diet level (45). Rabbits fed a low fat diet at 0.02, 
0.8 and 1.6% calcium resulted in elevated plasma cholesterol and 
phospholipids at the 0.02% level with no significant decrease at higher calcium 
supplements. Triglycerides showed no change. The lack of lipid lowering effect 
may be due to the low fat content of the diet (20). 
Infusions of calcium carbonate by stomach tube at 2 - 4 grams daily 
prevented an increase in serum cholesterol and phospholipid, but not 
triglycerides, resulting from acute starvation. Not surprising, a decrease in 
serum calcium levels with starvation was also prevented (46). 
Human studies have also provided conflicting results on 
hypocholesterolemic effects of calcium. Yacowitz (47) supplemented four men 
with 2.66 grams per day of calcium. A decrease in serum cholesterol was 
observed in every case. Bieranbaum (19) gave two grams of calcium carbonate 
each day to eight hyperlipemic men and two women. A 25% decrease in serum 
cholesterol levels occurred over a year. A reversal of the cholesterol to 
phospholipid ratio from 1.04 to 0.92 was observed. Serum triglyceride and 
phospholipid decreased but not significantly. No side effects were seen. 
A 750 mg calcium plus 375 mg 02 supplement of elderly women resulted 
in a striking, highly significant decrease in serum cholesterol (21 ). A "weak" 
hypocholesterolemic effect was seen with two gram calcium supplementation of 
sixteen hyperlipidemic patients. Serum triglycerides did not change (48). 
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No change in serum cholesterol of triglyceride was seen in six patients 
(five were osteoporotic) given either organic salts (calcium glycerophosphate or 
calcium glucono-galactogluconate) or skimmed milk. A definite effect on 
cholesterol metabolism was indicated however (49). 
In eleven men supplemented at two calcium levels in saturated fat diets a 
small lowering of borderline statistical significance of serum cholesterol 
occurred. No change in serum cholesterol occurred n polyunsaturated fat diets 
with calcium supplementation (50). 
Dietary Calcium and Tissue Lipids 
Animal studies show a relationship between levels of dietary calcium and 
tissue lipids. Fleischman et al. (43) sacrificed Holtzman rats fed a high 
saturated fat diet with 2% added cholesterol with varying calcium levels. His 
results indicate that the decrease in serum lipids with increasing calcium intakes 
was not caused by deposition of those lipids in the tissues examined. No 
increase in tissue lipids corresponding to a decrease in serum lipids was seen. 
Liver cholesterol did drop 17% at the 0.2% calcium level with no more decrease 
at 1.2% calcium level. No changes in heart lipids or liver total lipids or 
phospholipids was observed. 
Yacowitz et al. (42) Holtzman rats fed corn oil or saturated fat diets at three 
calcium levels did not show a change in liver total lipids of cholesterol with 
increasing calcium. At 0.08% calcium, the corn oil diet rats had a higher 
deposition of lipids in liver and triglycerides in lungs compared to cocoa butter 
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fed rats. Increased calcium corresponded with lower triglycerides in lungs with 
rats fed unsaturated fats. 
Iacono (20) fed rabbits a low fat diet with three calcium levels. On the 
calcium deficient (0.02%) diet, liver cholesterol and phospholipids were high; 
lung cholesterol and phospholipids were low. On the high calcium diet heart, 
adrenal gland and skeletal muscle had a decrease in free cholesterol. Total 
phospholipids decreased in skeletal muscles. Tissue triglycerides increased in 
the kidney, skeletal muscle, and adrenal gland with increasing dietary calcium. 
Triglycerides varied independently of cholesterol and phospholipids . 
In a study with goats, Hines et al. (45) found the total lipid and cholesterol 
concentrations unaltered in liver, other viscera and carcass tissues. Increasing 
dietary calcium correlated with decreased total lipids in aortas. Addition of 
dietary cholecalciferol (D3) increased cholesterol content of the aortas. Rabbits 
fed increasing levels of calcium (.08, 0.2, and 2.0%) had decreasing aorta 
cholesterol content and decreased severity of plaque scoring (1.9+, 1.4+, and 
1.9+ respectively) (51). 
Dietary Calcium and Dietary Fats 
Dietary fats, which are usually trigycerides of long chain fatty acids, are 
emulsified in the intestinal lumen. Pancreatic lipase hydrolyzes ester linkages 
giving insoluble monoglyceride (MG) and free fatty acids (FFA) (52). The 
lipolysis products are rendered soluble by complexing with bile salts, which 
have detergent properties, to form particles called micelles. As micelles, the MG 
and FFA's are exposed to the apical surface of the intestinal cells where they are 
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absorbed. Bile salts are not absorbed at this point and can be and are reused. 
In bile, mixed micelles prevent precipitation of free cholesterol and 
phospholipids and subsequent gallstone formation by solubilizing the steroids 
with bile salts (53). Bile is an obligatory requirement for passage of cholesterol 
from intestinal lumen and lymph (54). 
In the upper intestine either calcium or magnesium can form insoluble 
soaps which are in turn poorly absorbed (52). In 1918 Bosworth (55) noted 
infants ingesting cow's milk, richer in soluble calcium salts than human milk, had 
increased calcium soaps in their stools. Fecal fat (52) and fecal calcium (56) 
excretion increases significantly with increasing amounts of dietary calcium. 
The extent of soap formation with fats depends on ionized calcium levels in the 
intestinal lumen, though the solubility of soaps formed determines actual 
amounts appearing in feces (48). 
Excess dietary calcium seems to interfere with absorption of fat in poultry 
and rats (46,54). Increasing any type of dietary fat above five percent decreases 
calcium, iron, magnesium and zinc retention in chicks (58). 
The effect of dietary calcium on fat absorption varies with the type of fat. 
Removal of calcium (or magnesium) from a diet dramatically increased the 
digestability of fats. For example, the digestion of trilaurin is increased by 17% 
by the removal of calcium. A decrease in fat excreted as soap and an increase 
in the neutral free fatty acid fraction was also observed. Effects of calcium and 
magnesium salts are progressive, as their amount increases so does the 
observed effect (56). 
16 
In lambs, decreased ration digestibility by corn oil was alleviated by 
calcium carbonate and/or calcium chloride. Magnesium was not effective. It is 
thought that fatty acids are acting as antimetabolites to rumen bacteria, thus 
decreasing ration digestability. The addition of calcium causes precipitates of 
the fatty acids as calcium soaps and allows the remainder of the ingesta to 
ferment normally. Fecal calcium increased with added dietary calcium (59). 
Saturated fats are hypercholesterolemic. Lauric, myristic and palmitic 
acids are twice as effective in raising cholesterol as polyunsaturated fats are at 
lowering them. A high polyunsaturated to saturated fat ratio is recommended in 
cholesterol lowering diets (60). 
Polyunsaturated fats decrease blood cholesterol and intestinal 
cholesterolgenesis and sometimes increase liver cholesterol concentration 
(61 ,62). The hypocholesterolemic mechanism of polyunsaturated fats may be 
due to decreased cholesterolgenesis in the intestine, or redistribution of 
cholesterol from plasma to liver (61) but does not involve inhibition of intestinal 
absorption of sterols (62). If bile cholesterol excretion is an index of hepatic 
turnover of cholesterol, polyunsaturated fats may reduce plasma cholesterol by 
increasing cholesterol turnover since polyunsaturated fats increase production 
of bile acids in animal experiments (62). 
Increased ingestion of calcium increases fecal cholesterol and degree of 
saturation of fecal lipids in rats (43). Saturated fat diets supplemented at 3 
increasing levels of calcium resulted in 44, 52, and 103% greater fat excretion 
than polyunsaturated fat diets supplemented at 3 calcium levels. The hypo-
cholesterolemic effect of calcium is more pronounced in saturated fat diets (42). 
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Dietary Calcium and Serum Calcium Levels 
Dietary calcium level has no effect on serum calcium levels in women (21) 
and rabbits (46). In calcium supplemented women, serum calcium, serum 
phosphorus and their ratios, and urinary calcium excretion shows no change 
(21 ). Holtzman rats in calcium fed diets had increased serum calcium with no 
change in total calcium, magnesium, calcium:magnesium ratio, inorganic 
phosphate, proteins or albumins in their serum (33). 
The Role of Calcium in Arterial Calcification 
An adequate calcium supply is necessary for atherogenesis to occur (45). 
Atheromatous lesions are characterized by lipid accumulation, blood products, 
fibrous tissue and large deposits of calcium and magnesium. It is unknown 
whether calcification is a primary or secondary condition in atherosclerosis (27). 
Once extensively calcified the lesions do not regress (45). 
Moon (27) asserts that United States calcium intakes are too high and that 
this alone is sufficient to cause arterial calcification. Studies in goats do not 
support Moon's theory. Aortic calcification in goats was increased five fold when 
dietary calcium and D3 were fed together in large quantities but not when 
dietary calcium or D3 were given alone. Aortic magnesium deposits were 
• 
higher in calcium plus D3 fed animals (45). Dietary cholecalciferol (D3) is a 
positive risk factor for atherosclerosis. Hypervitaminosis D is atherogenic 
(27,44,45). 
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Goats fed differing calcium levels and/or o3 showed no change in serum 
calcium concentration. Aortic lipids were lowered in o3 supplemented groups 
when calcium supplementation was added; dietary calcium lowered aortic lipids 
even when very high levels of 03 were fed (45). Increased dietary calcium has 
been shown to reduce atheroma formation (51). 
Calcium depositions may not be directly caused by high levels of calcium 
but by the action of vitamin D on arterial cells (45). One theory proposes that 
hypercholesterolemia, in addition to developing lipid complexes in lesions, may 
function as an agent sensitizing arterial cells to calcium ("calciphylactic 
hypersensitivity"), resulting in increased calcium deposition (27). 
High dietary or serum cholesterol could result in an increase synthesis of 
vitamin 0 3. In the intestinal wall dietary cholesterol converts to a 15:1 
cholesterol: ?-dehydrocholesterol (provitamin 03) equilibrium mixture (27). 
Hines, et al. (45) suggests that the main effect of dietary calcium and o3 may be 
their influence on aortic calcification rather than cholesterol and total lipid 
metabolism (45). 
Dietary Calcium and Hypertension 
The National Center for Health Statistics, Health and Nutrition Examination 
Survey I (HANES I) found low calcium consumption was the most consistent 
factor in hypertensive persons. Dietary intake of calcium, potassium and sodium 
were positively correlated with lower mean systolic blood pressure and risk of 
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hypertension (22). Serum calcium was directly related to diastolic pressure in 
white people (24). 
Calcium supplementation of young adults resulted in a significant 
decrease of 5.6% and 9% in the diastolic blood pressure of women and men, 
respectively. No difference in serum calcium was found (35). Low serum 
concentration of ionized calcium has been found in humans with hypertension 
(64). 
A lack of effect of oral calcium supplements on blood pressure and 
vascular response was seen in normotensive men. Blood pressure, serum 
calcium, ionized serum calcium, serum magnesium, and urinary calcium were 
not altered with dietary calcium supplementation (65). 
The mechanisms involved in the relationship between calcium and 
hypertension are unclear (64), but they may be due to calcium's vasorelaxing, 
membrane stabilizing effect in vascular smooth muscle which could decrease 
vascular resistance (23). In the HANES I survey dietary calcium intake was 
inversely correlated with body mass and this may be related to decreased 
hypertension observed (22). 
The Atherogenicity of Dietary Proteins 
The relationship between animal and vegetable proteins and serum 
cholesterol levels was first recognized by lgnatoswki in 1909 (66). Subsequent 
research, however, focused on the cholesterol content of animal and vegetable 
diets rather than on the proteins themselves. In 1941 Meeker and Kerter found 
casein to be more atherogenic in the absence of dietary cholesterol than soy 
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protein diets in rabbits. Casein plus 60 mg of cholesterol induced 
atherosclerosis six times as severe as a similar soy protein diet (67). 
Experimentally, casein is often used as a representative animal protein; soy is 
the usual vegetable protein used (1 0). 
In rabbits, casein affects cholesterol absorption , excretion, and transport 
more than soy protein (1 0). Carroll (68) found casein hypercholesterolemic and 
atherogenic but not soy. Casein fed rabbits had a slower plasma cholesterol 
turnover, less excretion of neutral steroids and bile acids and greater 
cholesterol absorption . Excess cholesterol in casein fed animals is reflected by 
increased low density lipoprotein (LDL) 68,69). In mice, soy diets decreased 
plasma cholesterol and increased intestinal bile acids, suggesting increased 
bile secretion may mediate the hypocholesterolemic effect (70). In rats, casein 
results in higher serum cholesterol than soy diets with a corresponding increase 
in the VLDL fraction. Kinetic studies indicate that the accumulation of VLDL in 
rats fed casein diets is due to deficient VLDL removal by the liver (71 ). 
A casein diet which increases serum cholesterol, LDL and VLDL suggests 
a decreased clearance of plasma cholesterol - perhaps due to a decreased 
number of LDL receptors in the liver, which in turn is expressed by a reduced 
biliary steroid output (72). 
In chickens fed soy, egg white or lactalbumin protein diets, only a very 
small decrease in plasma cholesterol occurred in the soy diet (73). A study of 
protein quality and quantity in chickens found no difference in soy or casein 
feeding on serum or liver cholesterol. Twenty percent protein diets, either soy or 
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casein, increased cholesterol and VLDL. Fifty percent soy or protein diets 
prevented the hypercholesterolemic response (74). 
Experiments involving the feeding of different levels of soy or whey to 
Japanese quail gave results which indicated that plant and animal proteins 
were both hypocholesterolemic at high levels (75). 
Various human studies have found no change in serum cholesterol with 
soy or protein diets (76,77,78,79) although an increase in HDL was observed on 
isolate soy diets (76,78). One study of people fed animal or vegetable protein 
revealed a population of responders, whose serum cholesterol were lowered by 
experimental diets, and a portion of nonresponders, who showed no change. In 
the responders both soy and casein were hypocholesterolemic. Animal protein 
diets were more hypocholesterolemic (16% reduction) than soy protein (13% 
reduction) (80). In monkeys no change in serum total cholesterol with different 
types of protein diets was seen, although HDL increased and VLDL decreased 
in soy protein diets (81 ). 
A study feeding three proteins (caseinate, soya isolate, and soya 
concentrate) to three species (man, rabbit and rat) found caseinate to increase 
total cholesterol in rabbits, slightly in rats and none at all in humans. This 
indicates the problems in extrapolating results from animal studies to humans 
(78). It is uncertain whether casein is hypercholesterolemic or soy is 
hypocholesterolemic. Mechanisms of action have not been determined. 
The amino acid composition, specifically the lysine/arginine ratio, may 
account for the differing cholesterolemic effects of these proteins. The 
lysine/arginine ratio in casein is 2; for soy is 1. Adding lysine to soy diets 
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increases cholesterol turnover time in rabbits and expands body cholesterol 
pools. Casein with additional arginine is not less hypercholesterolemic than 
casein alone. Diluting casein with soy normalizes cholesterolemic effects of 
casein as the ratio approaches 1 :1 (82). 
Van der Meer proposed that the hypercholesterolemic effect of casein is 
related to its phosphorylation state. Calcium may bind to casein, a highly 
phosphorylated protein, forming calcium phosphate sediments which reduces 
calcium availability for interaction with biliary micelles. More micelles would be 
available for reabsorption, thus decreasing steroid excretion and increasing 
cholesterol. Additional dietary calcium could ameliorate the cholesterolemic 
effect of casein (83). 
Samman and Roberts extended this hypothesis to include casein 
interfering with the bioavailability of other divalent cations, zinc and copper, in 
the intestinal lumen. Their data in rabbits suggests supplementation of zinc or 
copper may render casein less hypercholesterolemic (67). 
Cholesterol 
Description 
Cholesterol (3-hydroxy-5,6-cholestene) is a steroid usually found in 
association with animal fats. It is synthetized in animal tissue and is essential for 
normal cell function. It is a precursor to all steroids synthesized in vivo. 
Endogenous sythesis contributes to most of the body cholesterol; dietary 
sources provide a small fraction. Elimination occurs by conversion to bile acids 
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or as excretion of fecal neutral steroids. High plasma cholesterol is positively 
correlated with atherosclerosis and accumulates in atherosclerotic plaques 
(84,85,86). 
Absorption of Cholesterol 
Endogenous (biliary) and exogenous (dietary) cholesterol are present in 
the intestine. The intestinal mucosa also synthesizes small amounts of 
cholesterol. Unesterified biliary cholesterol outputs are 800-1200 mg daily 
compared to 400-500 mg daily of dietary cholesterol in adults (84). 
Dietary cholesterol is deesterified by pancreatic cholesterol esterase (84). 
Bile acids, fatty acids, monoglycerides and lysolecithin form mixed micelles with 
cholesterol and are essential for cholesterol absorption (53,54,84,85). 
Cholesterol enters intestinal cells by monomolecular passive diffusion through 
the lipid of the membrane. The rate limiting step is absorption is probably not 
penetration but passage through the unstirred layer (84). 
Cholesterol Transport 
Once absorbed, hydrophobic cholesterol and other lipids are transported 
in the blood and lymph as lipoproteins. The largest lipoproteins, chylomicrons 
and very low density lipoproteins (VLDL) are droplets of triglyceride and 
unesterified cholesterol emulsified by a surface layer of phospholipid and free 
cholesterol (53). 
VLDL are derived from the intestine and liver. They carry 2% protein and 
98% lipid. Eighty-seven percent of these lipids are triacylglycerol, 8% 
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phospholipid, 3% cholesterol ester and 1% free cholesterol. VLDL carry lipids 
from the liver and gut to peripheral tissues (86). 
Chylomicrons release FFA from TG after hydrolysis by lipoprotein lipase, 
leaving chylomicron remnants (84). In the liver, cholesterol esters of 
chylomicrons are hydrolyzed and taken up by the liver. A portion of VLDL are 
formed in the liver and transport cholesterol in the plasma (86). VLDL encounter 
lipoprotein lipase in capillaries in peripheral tissues releasing fatty acids which 
enter cells of adipose and muscle tissue (87). This leaves intermediate density 
lipoproteins which convert to low density lipoproteins (LDL) by acquiring more 
cholesterol ester in their core. 
LDL may also be secreted by the liver, independently of VLDL by an 
unknown method (84). LDL particles are TG poor and contain 70% of the 
circulating cholesterol in man. Cholesterol may enter vessel walls as LDL (87). 
Eighty percent of LDL is removed from the plasma by specific cell surface 
receptors which promote internalization and release of cholesterol in LDL (88). 
Polar lipids and apolipoproteins left from the LDL transfer to HDL. HDL particles 
carry cholesterol away from tissues to the liver, where HDL is a precursor for bile 
acids and biliary cholesterol, thus providing a route of cholesterol elimination 
from the body (97). 
Nascent HDL discs are secreted by the liver and pick up cholesterol from 
cells. Lecithin cholesterol acyl tranferase enzyme esterifies free cholesterol to 
cholesterol esters which are hydrophobic. These enter the core of HDL, making 
it spherical (88). A fraction of HDL, HDL-1, may reduce cellular uptake of 
circulating cholesterol by competing with LDL for lipoprotein receptors on 
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smooth muscle cells (87). In vitro, HDL can decrease uptake of LDL by aortic 
smooth muscle, vascular endothelium and fibroblasts. HDL may be protective 
against atherosclerosis because of these functions (88). 
The Japanese Quail as an Experimental 
Model in Atherosclerosis Research 
The Japanese quail (Coturnix coturnix japonica) has proved a useful 
animal model for atherosclerosis research (89,90,91) particularly in nutritional 
(92,93,94) and pharmacological (90) studies. 
Quail are small, omnivorous, easily handled and cost effective (92,95). 
Sexual maturity is reached at 42 days from hatching. Physiological aging is fast 
and lifespan short (95). 
Unlike rats and mice (90,91) quail are susceptible to spontaneous or 
cholesterol induced atherosclerosis (92). Birds fed added cholesterol at 0.5%, 
as in this study, developed atherosclerosis, where quail not fed cholesterol did 
not develop it (90). 
Quail, especially males, carry the majority of serum cholesterol in HDL and 
absolute amounts of HDL increase with cholesterol feeding. Males have more 
atherosclerotic disease than females (90). 
Histologically, quail atherosclerotic lesions are similar to human lesions. 
Lesions are characterized by massive lipid deposition, myofibroblastic 
proliferation, and in order quail fibrocelluar lesions and adherent thrombi 
(92,96). Calcification, severe coronary atherosclerosis and death from 
myocardial infarction have also been reported (92). 
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Atherogenic responses vary due to genetics of quail at different 
laboratories (92). Japanese quail have been selectively bred into strains 
susceptible and resistant to atherosclerosis (91 ). Macroscopic lesions in the 
susceptible strain are similar to early fatty streaks in man (97). These strains 
should be useful in providing etiological information on atherosclerosis (97). 
These selectively bred strains were not utilized in this study. 
CHAPTER Ill 
MATERIALS AND METHODS 
Design 
Male Japanese quail (Coturnix coturnix japonica) were fed from hatching to 
eight weeks of age with Ralston Purina Game Bird Startena. At six weeks 
demineralized water was given in watering jars in place of tap water. At eight 
weeks of age twenty birds were sampled to serve as pre-diet controls. 
The remaining eighty birds were weighed, banded and randomly assigned 
to one of four dietary treatments which varied by protein source and calcium level. 
The quail were allowed food and demineralized water ad libitum throughout the 
study. After eight weeks on experimental diets the quail were terminated. 
Quail were housed in metal batteries in a room with controlled temperature 
(18"C) and constant light. The top four tiers of a 58" x 37.5" x 72" chick battery 
were utilized. Each tier of the battery was divided into four pens with dimensions 
of 36" x 18.75 "x 9.5" (5.01 square feet). Five birds from each diet treatment were 
randomly assigned to one pen per tier, for a total of four pens per diet with one diet 




Diet Composition is given in Table 1. Diets varied by protein source (soy 
protein or casein) and calcium content. Diets supplied 24% crude protein 
regardless of source. The low calcium diets met the nutrient requirement (0.8% 
calcium) so no calcium deficiency existed (98). High calcium diets supplied twice 
the requirement (1.6%) for nonbreeding male quail. Calcium was added as 
calcium carbonate and dicalcium phosphate. 
Corn oil, an unsaturated fat, was used. All diets had cholesterol added at 
0.5% to provide a ration which is known to be cholesterolemic, at 24% crude 
protein, to Japanese quail (99). 
Sample Collection 
Approximately five milliliters of blood was collected from each animal by 
decapitation. Twenty quail were sacrificed before experimental diets began. 
After eight weeks on treatment diets the remaining birds were bled. 
Blood was collected in 50 milliliter beakers containing 50 microliters of ten 
percent ethylene diamine tetraacetic acid (EDTA) with a pH of 7.4. Samples 
were mixed by swirling, transferred to glass tubes and kept on ice until 
centrifugation. 
Tubes were centrifuged at 1000 G for five minutes. Plasma was removed 
and put in capped plastic vials and stored at -28·c until analyzed. 
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TABLE I. 
EXPERIMENTAL DIETS (PERCENT) 
SOY+ SOY+ CASEIN + CASEIN + 
0.8% 1.6% 0.8% 1.6% 
CALCIUM CALCIUM CALCIUM CALCIUM 
CORNSTARCH 57.43 53.51 59.82 55.86 
SOY PROTEIN* 28.43 28.48 0.0 0.0 
CASEIN* 0.0 0.0 25.26 25.26 
GLISTA SALTS* 5.37 5.37 5.37 5.37 
POLYOLEFIN 3.0 3.0 3.0 3.0 
Dl CALCIUM 
PHOSPHATE 2.15 5.62 3.35 6.86 
CORN OIL 2.0 2.0 2.0 2.0 
CALCIUM 
CARBONATE 0.87 1.32 0.50 0.95 
CHOLESTEROL 0.50 0.50 0.50 0.50 
VITAMIN 
PREMIX 0.20 0.20 0.20 0.20 
*Product analysis in Appendixes A, B, and C 
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Sample Analysis 
Analysis of Total Cholesterol 
Plasma samples were thawed in a 40"C water bath. Thawed samples 
were vortexed for ten seconds. The following procedure, based on the 
Lieberman-Burchard reaction (1 00), was used: 
(1) Twenty JJ.I of sample was placed in a twenty-milliliter test tube 
(2) 0.2 ml of acetic acid-chloroform (3:2) reagent was added 
(3) 5.0 ml of chloroform-acetic anhydride reagent (1 0:3) was added 
and mixed briefly 
(4) 0.2 ml of reagent grade concentrated sulfuric acid was added then 
immediately and thoroughly vortexed 
(5) Samples were centrifuged at 1 000 G for ten minutes. The clear 
supernatant was decanted into 12 x 75 mm fluorometer tubes 
(6) Forty minutes after the addition of sulfuric acid fluorescence was read 
using a Turner Fluorometer Model 111. 
Plasma samples, blanks and aqueous standards (Sigma Chemical 
Company catalog #350-11) were run simultaneously. 
Analysis of HDL Cholesterol 
Serum LDL and VLDL were precipitated from plasma by Mg++ 
phosphotungstate and removed by centrifugation (1 01 ). The cholesterol 
associated with the soluble HDL fraction remains in the supernatant and is 
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quantified using the fluorometric method described for analysis of total 
cholesterol. 
The procedure for separating HDL is: 
(1) 0.4 ml of plasma was placed in a 15 ml conical centrifuge tube 
(2) 0.05 ml of HDL precipitating reagent (Mg++ phosphotungstate) was 
added and mixed by vortexing 
(3) Tubes were then centrifuged at 2000 G for five minutes to obtain a 
clear supernatant 
(4) The supernatant was then analyzed for total cholesterol using the 
procedure described in "Analysis of Total Cholesterol" above. 
Statistical Analysis 
Data was analyzed using analysis of variance. Where appropriate pairs of 
means were compared using the student's test (1 02). 
CHAPTER IV 
RESULTS 
Plasma Total Cholesterol 
Figure 1 shows plasma total cholesterol and HDL in mg/dl for the 
commercial ration control and the four treatment diets. The control commercial 
diet represents the average plasma cholesterol concentrations of eight week old 
birds (169.4 ± 8.19 mg/dl) before being placed on experimental diets. 
Post-treatment total plasma cholesterol levels were significantly higher (P = .01) 
than pre-treatment diets. 
Plasma total cholesterol in mg/dl, from highest to lowest levels, averages 
296.20 ± 22.34, 234.34 ± 19.05, 231.79 ± 14.81, and 208.50 ± 15.15 for 
casein-low calcium, casein-high calcium, soy-low calcium and soy-high calcium 
diets respectively. These means are statistically different (P = .05) with the 
exception of the casein-high calcium and the soy-low calcium values, which are 
very similar (234.34 ± 19.05 and 231.79 ± 14.81 mg/dl). 
Total plasma cholesterol was significantly different (P = .05) for birds 
consuming vegetable and animal proteins. The soy protein diet, at both calcium 
levels, average 219.79 ± 10.64 mg/dl compared to the more 
hypercholesterolemic casein diet which averaged 264.48 ± 15.27 mg/dl over 
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Plasma cholesterol and HDL concentrations in mg/dl. Control birds 
(n = 20) were sacrificed at 8 weeks of age after consuming 
commercial ration from hatching. Soy-low calcium (n = 17), 
soy-high calcium (n = 18), casein-low calcium (n = 19) and 
casein-high calcium (n = 20) were sacrificed at 15 weeks of 
age after 17 weeks on treatment diets. Mean cholesterol 
concentrations were significantly different at the one percent level. 
No significant differences in HDL concentration exist. 
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The low calcium diets, regardless of protein source, averaged significantly 
higher (P = 0.05) total plasma cholesterol levels (265. 79 ± 14.57 mg/dl) than the 
high calcium diets (222.1 0 ± 12.35 mg/dl). 
No consistent significant differences in plasma cholesterol resulted due to 
blocking (tier) effects (F = 0.8) so differences in cholesterol levels are attributed 
to diet effects. 
Plasma HDL Cholesterol 
Plasma HDL concentrations (Figure 1) paralleled changes in total plasma 
cholesterol but the means of plasma HDL concentrations were not significantly 
different. The pre-treatment control group had a mean HDL of 11 0.57 ± 8.97 
mg/dl. Post-treatment HDL levels were higher, but not significantly so. 
HDL concentrations in mg/dl for quail on treatment diets were 147.59 ± 
9.78, 136.00 ± 12.06, 134.00 ± 9.28, and 130.47 ± 8.00 for birds on casein-low 
calcium, soy-low calcium, casein-high calcium and casein-low calcium 
respectively. Though these HDL changes correspond to fluctuations in plasma 
total cholesterol the magnitude of the changes is insufficient to be significantly 
different. 
Vegetable protein diets, averaged over both calcium levels, resulted in 
plasma HDL levels of 133.16 ± 7.07 mg/dl. Birds consuming the animal protein 
diets, averaged over calcium levels, had HDL values of 138.05 ± 6.15. The 
higher HDL level on the casein diet is not significantly different than soy HDL. 
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The HDL cholesterol of the two low calcium diets averaged 136 ± 12.06 
while the high calcium HDL was lower, 124.36 ± 1 0.37. These are not 
significantly different. 
Mortality 
Six quail died before termination of the experiment. One quail each died 
on weeks 2, 5 and 6 of the soy-low calcium diets. One quail each on the 
soy-high calcium diets died on weeks 3 and 5. One quail on the casein-low 
calcium diet died week six. Information on plasma lipid levels were not 
determined in these animals. No mortality occurred in the casein-high calcium 
diet. 
Weight Changes 
The mean weight of the control group was 136.0 ± 1.57 grams. 
Pre-treatment weights were 147.6 ± 2.7, 141.3 ± 2.3, 143.6 ± 2.6 and 142.4 ± 2.8 
grams for diet groups as listed above. Quail on the low calcium diets gained an 
average of 5.0 grams for soy diets and 8.73 grams on casein diets. Birds on the 
high calcium diets showed a slight tendency to lose weight. Average losses 




Cholesterolemic Effects of Dietary Calcium and Protein 
This study demonstrates a hypocholesterolemic effect of dietary calcium. 
Results are consistent with studies reporting hypercholesterolemic effects of 
animal proteins, like casein (70,71 ,75,83). Plasma HDL levels were not 
significantly altered by dietary treatment. 
The casein-low calcium diet was most hypercholesterolemic; soy-high 
calcium was the least with approximately seventy percent lower plasma total 
cholesterol. 
The data indicated that doubling the nutrient requirement level of calcium 
in a casein diet will lower plasma cholesterol to levels comparable to those 
resulting from a soy protein diet with no supplemental calcium. Additional 
dietary calcium lowered plasma cholesterol levels regardless of protein source. 
The lower plasma total cholesterol in the commercial diet may be due to its 
higher protein content. It contained 30% crude protein. The experimental diets 
had 24% crude protein. A hypocholesterolemic effect of high dietary protein in 





This study did not address mechanisms of the hypocholesteroemic effect of 
dietary calcium. Several possible mechanisms suggested by other investigators 
are discussed below. 
Little information is available on the role of calcium in lipid metabolism 
(49). The mode of calcium induced hypoch'?lesterolemia could be due to 
changes in cholesterol synthesis, absorption, conversion to bile acids, or 
changes in lipoprotein metabolism (37). Intravenous infusion of ionized calcium 
does not change serum cholesterol levels in humans (51). Many researchers 
think that calcium exerts its cholesterol lowering effects in the intestine, either by 
increased excretion of bile acids (46,51,52) or formation of insoluble complexes 
(42,49,52). 
Dietary calcium may act by sequestering bile acids and suppressing 
enterohepatic circulation of cholesterol; this is the mechanism of the drug 
cholestyramine (51). Fleischman et al (44) found a three fold elevation in bile 
acid excretion in calcium supplemented rats corresponding to a decrease in 
serum and tissue cholesterol, including a 17% decrease in liver cholesterol. 
The liver is where cholesterol is oxidized to bile acids. Thus, increased fecal 
bile salt excretion could lower the cholesterol pool of the body. The degree of 
calcium binding of bile acids is uncertain (50). 
Bhattacharyya (53) found no support for the hypocholesterolemic action of 
calcium mediated by increased excretion of bile acids in man. No change in 
fecal bile acid excretion occurred in polyunsaturated fat diets at two calcium 
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levels. Wells and Cooper (42) reported the failure of calcium to inhibit 
cholesterol absorption when added to fat free diets containing bile salts in rats. 
A relationship exists between the amount of dietary calcium and fat 
absorption (50,55,59,60). Addition of calcium decreases digestibility of dietary 
fats, especially saturated fats (59). 
When fat was omitted from rat's diets calcium did not inhibit cholesterol 
absorption suggesting calcium acts by forming insoluble complexes with 
phospolipids or fatty acids, inhibiting cholesterol absorption (42). 
Fecal calcium excretion increased with increasing dietary calcium equally 
with saturated and unsaturated fat diets in rats (43). Bhattacharyya (53) 
observed increased elimination of neutral steroids in men at varying calcium 
levels, only with polyunsaturated fats. No correlation between serum cholesterol 
changes corresponded with changes in neutral steroid excretion in individuals. 
In rats, a large increase in fecal lipids was not necessary for the cholesterol 
lowering effect of dietary calcium. Higher calcium levels did not decrease the 
degree of unsaturation of serum lipids so the mode of action may not be 
attributable to a change in the degree of unsaturation of absorbed fatty acids 
(44). 
Human calcium supplementation increased both fecal fat and cholesterol 
excretion with no drop in serum total cholesterol. Calcium did appear to effect 
cholesterol metabolism. 
Supplemented as calcium glycerophosphate, total neutral steroid 
excretion was unchanged while coprostanol excretion decreased, suggesting 
decreased bacterial conversion of cholesterol to coprostanol. In rats, bile acids 
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inhibit conversion of cholesterol to coprostanol and coprostanone by colon 
bacteria. Calcium reacting with bile acids result' in insoluble bile salts, which in 
high amounts, depress the above mentioned bacterial conversion, perhaps 
accounting for the increased cholesterol excretion seen (52). Calcium given as 
skim milk resulted in increased neutral steroid and bile acid excretion (52). 
In goats, dietary calcium was not shown to influence lipid absorption. No 
change in percent fecal lipid or fecal weight was observed in calcium carbonate 
supplemented animals through a slight, statistically insignificant, increase in 
total fecal lipids was observed (46). 
Calcium interference with cholesterol absorption was not seen in a human 
study where fecal neutral steroid did not change with changing calcium content 
in the diet. High calcium diets slightly increased fecal saturated fatty acids but 
observed serum cholesterol reductions could not be explained by decreased fat 
absorption alone. If it is assumed that the fats must be absorbed to alter serum 
cholesterol, some other mechanism(s) must be acting (53). 
A 25% lowering of serum total cholesterol with calcium supplementation 
resulted in reversal of the cholesterol:phospholipid ratio from 1.04 to 0.92. It was 
assumed HDL increased because as the ratio of phospholipid to other lipids 
increase, the density of serum lipoproteins increase (19). 
Another human study saw a decreased total cholesteroi:HDL ratio in high 
calcium control diets but a decreased ratio in skim milk diets. HDL could have 
been diverted to bile; bile cholesterol is derived from HDL (40). 
In rabbits, a high calcium diet alters the free cholesterol:total cholesterol 
ratio suggesting calcium effects hepatic lipoprotein syntesis or alters enzymes 
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involved in free and esterified cholesterol regulation. Phospholipid total 
cholesterol ratios in the liver changed with dietary calcium levels indicating 
dietary calcium may participate in the regulation of tissue phospholipids and 
total cholesterol (20). 
More information on the interaction of dietary calcium with mechanisms 
involved in cholesterol absorption, excretion and metabolism before calcium's 
hypocholesterolemic mechanism is understood. 
Summary 
(1) An increased level of dietary calcium was hypocholesterolemic in 
quail fed a diet with 0.5% added cholesterol. 
(2) Casein was more hypercholesterolemic than soy protein, except when 
supplemented with dietary calcium. 
(3) Plasma HDL did not change significantly due to dietary manipulation. 
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SOYBEAN PROTEIN ANALYSIS 
Protein, N x 6.25 (as is basis: 90%+ 
Moisture: 4.8% 
Water- soluble protein 
(as% of total protein): 75% 
Crude fiber: 0.25% 
Ash: 4.0% 







Amino Acid Composition of Soybean Protein, Grade II 











Soybean protein supplied by: 
United States Biochemical Corporation 


















Product analysis provided by: 
Eire Casein Company, Inc. 
P.O. Box 648 
Eire, Illinois 61250 
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CALCIUM AND PHOSPHORUS DEFICIENT CHICK MINERAL MIX 
TO 84456 
g/kg 
Sodium Chloride NaCI 164.0894 
Potassium Bicarbonate KHC03 192.9423 
Magnesium Sulfate MgS04•7H20 65.2626 
Manganese Sulfate MnS04•H20 12.121 
Ferric Citrate 9.3222 
Zinc Carbonate 1.8659 
Cupric Sulfate CuS04•SH20 0.3724 
Boric Acid 0.1676 
Sodium Molybdate Na2MoO 4 •2H20 0.1676 
Potassium Iodide Kl 0.7467 
Cobalt Sulfate CoS04•7H20 0.0186 
Sodium Selenite Na2seo3 0.0037 
Corn Starch 552.92 
Designed for use at 5.37% of chick diet. This formula is a modification of TO 
73007. The lot number used was 403293. 
This Glista Salt mineral mix was formulated by: 
TEKLAD 
P.O. Box 4200 
Madison, WI 53771 
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